Robert  Willis net worth and biography

Robert Willis Biography and Net Worth

EVP of Perrigo
Rob Willis was appointed Executive Vice President and Chief Human Resources Officer (CHRO) of Perrigo in August 2019 after serving as Vice President of Human Resources Global Businesses for nearly six years. Prior to joining Perrigo, Mr. Willis gained more than 20 years of experience in Human Resources leadership through roles with Fawaz Alhokair Group in the Middle East, GE Capital in the UK and Ireland, DoubleClick in North America and internationally, and Norkom Technologies in Europe and North America. He also was a Partner and Founding Member of the Black & White Group.

What is Robert Willis' net worth?

The estimated net worth of Robert Willis is at least $667,039.85 as of February 29th, 2024. Mr. Willis owns 25,105 shares of Perrigo stock worth more than $667,040 as of November 13th. This net worth evaluation does not reflect any other investments that Mr. Willis may own. Learn More about Robert Willis' net worth.

How old is Robert Willis?

Mr. Willis is currently 55 years old. There are 5 older executives and no younger executives at Perrigo. The oldest executive at Perrigo is Mr. Svend Andersen, Executive VP & President of Consumer Self-Care International, who is 62 years old. Learn More on Robert Willis' age.

How do I contact Robert Willis?

The corporate mailing address for Mr. Willis and other Perrigo executives is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. Perrigo can also be reached via phone at (531) 709-4000 and via email at [email protected]. Learn More on Robert Willis' contact information.

Has Robert Willis been buying or selling shares of Perrigo?

Robert Willis has not been actively trading shares of Perrigo during the last ninety days. Most recently, on Thursday, February 29th, Robert Willis bought 6,000 shares of Perrigo stock. The stock was acquired at an average cost of $25.87 per share, with a total value of $155,220.00. Following the completion of the transaction, the executive vice president now directly owns 25,105 shares of the company's stock, valued at $649,466.35. Learn More on Robert Willis' trading history.

Who are Perrigo's active insiders?

Perrigo's insider roster includes Bradley Alford (Director), Svend Andersen (EVP), Eduardo Bezerra (CFO), Rolf Classon (Director), James Dillard, III (EVP), Thomas Farrington (EVP), Alison Ives (EVP), Ronald Janish (EVP), Murray Kessler (CEO), Todd Kingma (VP), Patrick Lockwood-Taylor (CEO), Geoffrey Parker (Director), Grainne Quinn (EVP), Theodore Samuels, II (Director), Raymond Silcock (CFO), Richard Sorota (EVP), and Robert Willis (EVP). Learn More on Perrigo's active insiders.

Are insiders buying or selling shares of Perrigo?

During the last twelve months, Perrigo insiders bought shares 8 times. They purchased a total of 42,580 shares worth more than $1,199,876.50. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 50,254 shares worth more than $1,411,969.20. The most recent insider tranaction occured on September, 13th when Director Katherine C Doyle sold 8,954 shares worth more than $244,444.20. Insiders at Perrigo own 0.7% of the company. Learn More about insider trades at Perrigo.

Information on this page was last updated on 9/13/2024.

Robert Willis Insider Trading History at Perrigo

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024Buy6,000$25.87$155,220.0025,105View SEC Filing Icon  
11/24/2023Buy5,550$31.01$172,105.5019,105View SEC Filing Icon  
See Full Table

Robert Willis Buying and Selling Activity at Perrigo

This chart shows Robert Willis's buying and selling at Perrigo by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perrigo Company Overview

Perrigo logo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $26.80
Low: $26.33
High: $26.87

50 Day Range

MA: $26.04
Low: $24.18
High: $28.49

2 Week Range

Now: $26.80
Low: $23.89
High: $34.60

Volume

2,146,279 shs

Average Volume

1,626,817 shs

Market Capitalization

$3.66 billion

P/E Ratio

N/A

Dividend Yield

4.19%

Beta

0.48